We are live on ! Find out more
EIDX

Eidos Therapeutics, Inc. Common Stock
EIDX

Delisted

EIDX was delisted on the 25th of January, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Eidos Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 120 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 121 → 0 (-121)

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $1.45B → $0 (-$1.45B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 120

Holders
–
Holders Change
-121
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
120
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$205M
2
ACM
Aisling Capital Management
New York
-$148M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$119M
4
PA
Perceptive Advisors
New York
-$90.4M
5
MF
Magnetar Financial
Illinois
-$78.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
Pentwater Capital Management
Florida
– -$16M -121,933 Closed
Man Group
27
Man Group
United Kingdom
– -$14.2M -107,912 Closed
AllianceBernstein
28
AllianceBernstein
Tennessee
– -$13M -98,894 Closed
Westfield Capital Management
29
Westfield Capital Management
Massachusetts
– -$12.3M -93,422 Closed
Citigroup
30
Citigroup
New York
– -$11.4M -87,000 Closed
CCM
31
Chicago Capital Management
Illinois
– -$10.5M -79,922 Closed
Charles Schwab
32
Charles Schwab
California
– -$9.45M -71,774 Closed
CS
33
Candriam SCA
Luxembourg
– -$8.89M -67,551 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
34
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$8.74M -66,400 Closed
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
– -$6.21M -47,214 Closed
N
36
Nuveen
North Carolina
– -$6M -45,568 Closed
Bank of New York Mellon
37
Bank of New York Mellon
New York
– -$5.88M -44,720 Closed
GF
38
Gabelli Funds
New York
– -$5.18M -39,400 Closed
KPF
39
K2 Principal Fund
Ontario, Canada
– -$3.96M -30,093 Closed
Russell Investments Group
40
Russell Investments Group
United Kingdom
– -$3.88M -29,544 Closed
Aviva
41
Aviva
United Kingdom
– -$3.67M -27,877 Closed
Morgan Stanley
42
Morgan Stanley
New York
– -$3.55M -26,967 Closed
KC
43
Kellner Capital
New York
– -$3.47M -26,357 Closed
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
– -$3.42M -25,982 Closed
PCM
45
Prelude Capital Management
New York
– -$3.37M -25,622 Closed
California Public Employees Retirement System
46
California Public Employees Retirement System
California
– -$2.95M -22,400 Closed
Swiss National Bank
47
Swiss National Bank
Switzerland
– -$2.87M -21,800 Closed
PHP
48
Parkman Healthcare Partners
Connecticut
– -$2.84M -21,609 Closed
Wells Fargo
49
Wells Fargo
California
– -$2.69M -20,406 Closed
VI
50
Versor Investments
New York
– -$2.63M -20,006 Closed
1
2
3 4 5

EIDX Hedge Fund Activity: Q1 2021 in Review

0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Eidos Therapeutics, Inc. Common Stock (EIDX) for Q1 2021, worth a combined $0 — down 100% from $1.45B a quarter earlier.

Sellers outnumbered buyers: 120 funds closed out of EIDX and 0 opened new positions — a net loss of 120 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $205M sold.

  • 0 institutional investors held Eidos Therapeutics, Inc. Common Stock (EIDX) as of Q1 2021, down from 121 in Q4 2020.
  • Funds reported $0 of Eidos Therapeutics, Inc. Common Stock stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Eidos Therapeutics, Inc. Common Stock positions in Q1 2021 and 120 closed out, a net change of -120 holders.
  • The largest Eidos Therapeutics, Inc. Common Stock seller in Q1 2021 was BlackRock, an estimated $205M sold.

Based on aggregated 13F filings for Q1 2021.